Our results, presented in Figure 7A through ROC curves, demonstrated that PIVKA-II and HIST1H3G exhibited superior sensitivity than AFP in assessing the survival outcomes of HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.